butyrylcarnitine has been researched along with hexanoylcarnitine in 3 studies
Studies (butyrylcarnitine) | Trials (butyrylcarnitine) | Recent Studies (post-2010) (butyrylcarnitine) | Studies (hexanoylcarnitine) | Trials (hexanoylcarnitine) | Recent Studies (post-2010) (hexanoylcarnitine) |
---|---|---|---|---|---|
29 | 2 | 13 | 18 | 0 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pourfarzam, M; Turnbull, DM; Tyni, T | 1 |
Alexandre-Gouabau, MC; Antignac, JP; Courant, F; Darmaun, D; Küster, A; Le Gall, G; Moyon, T; Tea, I | 1 |
Davies, AH; Holmes, E; Lewis, MR; Nicholson, JK; Shalhoub, J; Spagou, K; Vorkas, PA; Want, EJ | 1 |
3 other study(ies) available for butyrylcarnitine and hexanoylcarnitine
Article | Year |
---|---|
Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acetylcarnitine; Acyl-CoA Dehydrogenase; Carnitine; Carnitine O-Palmitoyltransferase; Cells, Cultured; Fatty Acid Desaturases; Fatty Acids; Fibroblasts; Humans; Mass Spectrometry; Metabolic Diseases; Mitochondria; Muscle, Skeletal; Myoblasts; Oxidation-Reduction; Skin | 2002 |
Maternal and cord blood LC-HRMS metabolomics reveal alterations in energy and polyamine metabolism, and oxidative stress in very-low birth weight infants.
Topics: Biogenic Polyamines; Carnitine; Female; Fetal Blood; Gestational Age; Glutamic Acid; Glutamine; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Maternal-Fetal Exchange; Pregnancy | 2013 |
Metabolic Phenotypes of Carotid Atherosclerotic Plaques Relate to Stroke Risk: An Exploratory Study.
Topics: Aged; Aged, 80 and over; Arachidonic Acid; Biomarkers; Carnitine; Carotid Stenosis; Case-Control Studies; Female; Humans; Male; Metabolomics; Middle Aged; Palmitoylcarnitine; Phenotype; Plaque, Atherosclerotic; Risk Factors; Stroke | 2016 |